World's Best Scientists 2026 revealed!
Michio Imamura

Michio Imamura

D-Index & Metrics

Microbiology

D-Index
57
Citations
9938
World Ranking
3616
National Ranking
142

Overview

Michio Imamura is affiliated with Hiroshima University in Japan and has contributed extensively to the field of medicine, with a primary focus on hepatology and related subfields. Their research encompasses a broad spectrum within liver diseases, particularly hepatitis and hepatocellular carcinoma.

Imamura's publication record includes significant works related to liver disease diagnosis and treatment, hepatitis C virus research, hepatocellular carcinoma treatment and prognosis, and hepatitis B virus studies. Their contributions have been published in notable venues such as Research Square, Journal of Hepatology, Oncology, Cancers, and Clinical Journal of Gastroenterology.

Key recent papers authored or co-authored by Imamura include the following:

  • Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection (2022, New England Journal of Medicine)
  • Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma (2021, Oncology)
  • Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma (2020, Clinical and Translational Gastroenterology)
  • Road to elimination of HCV: Clinical challenges in HCV management (2021, Liver International)
  • Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy (2022, Journal of Hepatology)

Their frequent collaborators include Hiroshi Aikata, Takashi Nakahara, Tomokazu Kawaoka, Eisuke Murakami, and Kazuaki Chayama, each having co-authored multiple works alongside Imamura.

Imamura's main fields of study within medicine include:

  • Hepatology
  • Epidemiology
  • Oncology
  • Surgery
  • Pathology and Forensic Medicine

The scientist's research topics cover:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Cancer Mechanisms and Therapy
  • Cancer Immunotherapy and Biomarkers

Best Publications

  • Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

    Bruno Sainz;Naina Barretto;Danyelle N Martin;Nobuhiko Hiraga

  • HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.

    Nourdine Hamdane;Nourdine Hamdane;Frank Jühling;Frank Jühling;Emilie Crouchet;Emilie Crouchet;Houssein El Saghire;Houssein El Saghire

  • Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats.

    Michio Imamura;Michio Imamura;Tadashi Ogawa;Yasuyuki Sasaguri;Kazuaki Chayama

  • G to A hypermutation of hepatitis B virus

    Chiemi Noguchi;Hiromi Ishino;Masataka Tsuge;Yoshifumi Fujimoto

  • Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage.

    Mikiya Kitamoto;Michio Imamura;Koji Kamada;Hiroshi Aikata

  • Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.

    Masataka Tsuge;Nobuhiko Hiraga;Hideki Takaishi;Chiemi Noguchi

  • Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients

    Hiromi Abe;Hidenori Ochi;Toshiro Maekawa;C. Nelson Hayes

  • Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.

    Yuko Nagaoki;Hiroshi Aikata;Kana Daijyo;Yuji Teraoka

  • Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection

    Shanshan He;Billy Lin;Virginia Chu;Zongyi Hu

  • Genetics of IL28B and HCV—response to infection and treatment

    C. Nelson Hayes;Michio Imamura;Hiroshi Aikata;Kazuaki Chayama

  • The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration

    Nobuhiko Hiraga;Hiroshi Aikata;Shintaro Takaki;Hideaki Kodama

  • HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy

    C Nelson Hayes;Mariko Kobayashi;Norio Akuta;Fumitaka Suzuki

  • HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice

    Masataka Tsuge;Nobuhiko Hiraga;Rie Akiyama;Sachi Tanaka

  • IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy

    Hiromi Abe;C. Nelson Hayes;Hidenori Ochi;Toshiro Maekawa

  • Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice

    Masahiro Ohira;Kohei Ishiyama;Yuka Tanaka;Marlen Doskali

  • Recent trend of clinical features in patients with hepatocellular carcinoma

    Yuko Nagaoki;Hideyuki Hyogo;Hiroshi Aikata;Mio Tanaka

  • Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

    Takuya Matsumura;Zongyi Hu;Takanobu Kato;Marlene Dreux

  • A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.

    Keiichi Kosaka;Nobuhiko Hiraga;Nobuhiko Hiraga;Michio Imamura;Michio Imamura;Satoshi Yoshimi;Satoshi Yoshimi

  • Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b

    Tomokazu Kawaoka;C. Nelson Hayes;Waka Ohishi;Waka Ohishi;Hidenori Ochi

  • Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.

    Takashi Nakahara;Takashi Nakahara;Hideyuki Hyogo;Atsushi Ono;Atsushi Ono;Yuko Nagaoki;Yuko Nagaoki

  • Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo

    Nobuhiko Hiraga;Michio Imamura;Hiromi Abe;C. Nelson Hayes

Frequent Co-Authors

Kazuaki Chayama
Kazuaki Chayama Hiroshima University
Katsutoshi Yoshizato
Katsutoshi Yoshizato Osaka Metropolitan University
Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Fumitaka Suzuki
Fumitaka Suzuki Toranomon Hospital
Takaji Wakita
Takaji Wakita National Institute of Infectious Diseases
Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition
Shinji Tanaka
Shinji Tanaka Hiroshima University
Naoyuki Kamatani
Naoyuki Kamatani StaGen (Japan)
Tatsuhiko Tsunoda
Tatsuhiko Tsunoda University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities. Many professionals choose to enhance their skills by enrolling in accredited online mph programs easy to get into. These programs provide a public health perspective that complements microbiology expertise, preparing graduates for careers in epidemiology and health policy.

Career paths connected to microbiology also include specialized healthcare roles. For instance, becoming a child life specialist blends knowledge of health sciences with emotional support for young patients. Understanding how much does a child life specialist make can help guide students considering this vocation.

Furthermore, certain online degrees offer accessible options to non-traditional students, including those with prior convictions. Resources that highlight the college degrees for felons can provide valuable information on programs that support rehabilitation and career growth in the sciences.

For those interested in healthcare innovation, the path to becoming a functional medicine nurse practitioner merges clinical practice with an integrative approach to health. Learning how to become a functional medicine nurse practitioner offers insight into specialized training that complements microbiology backgrounds.

Best Scientists Citing Michio Imamura

Trending Scientists